Maximizing Trial Value in Resource-Constrained Biotechs

Send us Fan Mail In this episode of the Driving the Business of Science podcast, host Keith Parent, CEO of Court Square Group, speaks with Nathalie Riebel, CEO and founder of Oncospire Consultants, a consultancy specializing in small biotechs. Nathalie points to the $80 billion pharma outsourcing market and the performance and quality challenges that accompany it. The data consistently shows that this massive transfer of work is plagued by delays, quality failures, sponsor dissatisfaction, an...